Global CAR-T Cell Immunotherapy Market Growth (Status and Outlook) 2022-2028
- LP 4917061
- 64 Pages
- March 2022
- Medical Devices
The United States CAR-T Cell Immunotherapy market is expected at value of US$ million in 2021 and grow at approximately % CAGR during review period. China constitutes a % market for the global CAR-T Cell Immunotherapy market, reaching US$ million by the year 2028. As for the Europe CAR-T Cell Immunotherapy landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period. In APAC, the growth rates of other notable markets (Japan and South Korea) are projected to be at % and % respectively for the next 5-year period.
Global main CAR-T Cell Immunotherapy players cover Novartis AG, Kite Pharma, JW Therapeutics, and Shanghai Fosun Pharmaceutical Group, etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.
This report presents a comprehensive overview, market shares, and growth opportunities of CAR-T Cell Immunotherapy market by product type, application, key players and key regions and countries.
Segmentation by type: breakdown data from 2017 to 2022 in Section 2.3; and forecast to 2028 in section 10.7.
CD19
CD22
Other
Segmentation by application: breakdown data from 2017 to 2022, in Section 2.4; and forecast to 2028 in section 10.8.
Relapsed or Refractory Mantle Cell Lymphoma (MCL)
High Grade B Cell Lymphoma
DLBCL
Other
This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the major players in the market. The key players covered in this report: Breakdown data in in Chapter 3.
Novartis AG
Kite Pharma
JW Therapeutics
Shanghai Fosun Pharmaceutical Group
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
2 Executive Summary
2.1 World Market Overview
2.1.1 Global CAR-T Cell Immunotherapy Market Size 2017-2028
2.1.2 CAR-T Cell Immunotherapy Market Size CAGR by Region 2017 VS 2022 VS 2028
2.2 CAR-T Cell Immunotherapy Segment by Type
2.2.1 CD19
2.2.2 CD22
2.2.3 Other
2.3 CAR-T Cell Immunotherapy Market Size by Type
2.3.1 CAR-T Cell Immunotherapy Market Size CAGR by Type (2017 VS 2022 VS 2028)
2.3.2 Global CAR-T Cell Immunotherapy Market Size Market Share by Type (2017-2022)
2.4 CAR-T Cell Immunotherapy Segment by Application
2.4.1 Relapsed or Refractory Mantle Cell Lymphoma (MCL)
2.4.2 High Grade B Cell Lymphoma
2.4.3 DLBCL
2.4.4 Other
2.5 CAR-T Cell Immunotherapy Market Size by Application
2.5.1 CAR-T Cell Immunotherapy Market Size CAGR by Application (2017 VS 2022 VS 2028)
2.5.2 Global CAR-T Cell Immunotherapy Market Size Market Share by Application (2017-2022)
3 CAR-T Cell Immunotherapy Market Size by Player
3.1 CAR-T Cell Immunotherapy Market Size Market Share by Players
3.1.1 Global CAR-T Cell Immunotherapy Revenue by Players (2020-2022)
3.1.2 Global CAR-T Cell Immunotherapy Revenue Market Share by Players (2020-2022)
3.2 Global CAR-T Cell Immunotherapy Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 CAR-T Cell Immunotherapy by Regions
4.1 CAR-T Cell Immunotherapy Market Size by Regions (2017-2022)
4.2 Americas CAR-T Cell Immunotherapy Market Size Growth (2017-2022)
4.3 APAC CAR-T Cell Immunotherapy Market Size Growth (2017-2022)
4.4 Europe CAR-T Cell Immunotherapy Market Size Growth (2017-2022)
4.5 Middle East & Africa CAR-T Cell Immunotherapy Market Size Growth (2017-2022)
5 Americas
5.1 Americas CAR-T Cell Immunotherapy Market Size by Country (2017-2022)
5.2 Americas CAR-T Cell Immunotherapy Market Size by Type (2017-2022)
5.3 Americas CAR-T Cell Immunotherapy Market Size by Application (2017-2022)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC CAR-T Cell Immunotherapy Market Size by Region (2017-2022)
6.2 APAC CAR-T Cell Immunotherapy Market Size by Type (2017-2022)
6.3 APAC CAR-T Cell Immunotherapy Market Size by Application (2017-2022)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 Europe
7.1 Europe CAR-T Cell Immunotherapy by Country (2017-2022)
7.2 Europe CAR-T Cell Immunotherapy Market Size by Type (2017-2022)
7.3 Europe CAR-T Cell Immunotherapy Market Size by Application (2017-2022)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa CAR-T Cell Immunotherapy by Region (2017-2022)
8.2 Middle East & Africa CAR-T Cell Immunotherapy Market Size by Type (2017-2022)
8.3 Middle East & Africa CAR-T Cell Immunotherapy Market Size by Application (2017-2022)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Global CAR-T Cell Immunotherapy Market Forecast
10.1 Global CAR-T Cell Immunotherapy Forecast by Regions (2023-2028)
10.1.1 Global CAR-T Cell Immunotherapy Forecast by Regions (2023-2028)
10.1.2 Americas CAR-T Cell Immunotherapy Forecast
10.1.3 APAC CAR-T Cell Immunotherapy Forecast
10.1.4 Europe CAR-T Cell Immunotherapy Forecast
10.1.5 Middle East & Africa CAR-T Cell Immunotherapy Forecast
10.2 Americas CAR-T Cell Immunotherapy Forecast by Country (2023-2028)
10.2.1 United States CAR-T Cell Immunotherapy Market Forecast
10.2.2 Canada CAR-T Cell Immunotherapy Market Forecast
10.2.3 Mexico CAR-T Cell Immunotherapy Market Forecast
10.2.4 Brazil CAR-T Cell Immunotherapy Market Forecast
10.3 APAC CAR-T Cell Immunotherapy Forecast by Region (2023-2028)
10.3.1 China CAR-T Cell Immunotherapy Market Forecast
10.3.2 Japan CAR-T Cell Immunotherapy Market Forecast
10.3.3 Korea CAR-T Cell Immunotherapy Market Forecast
10.3.4 Southeast Asia CAR-T Cell Immunotherapy Market Forecast
10.3.5 India CAR-T Cell Immunotherapy Market Forecast
10.3.6 Australia CAR-T Cell Immunotherapy Market Forecast
10.4 Europe CAR-T Cell Immunotherapy Forecast by Country (2023-2028)
10.4.1 Germany CAR-T Cell Immunotherapy Market Forecast
10.4.2 France CAR-T Cell Immunotherapy Market Forecast
10.4.3 UK CAR-T Cell Immunotherapy Market Forecast
10.4.4 Italy CAR-T Cell Immunotherapy Market Forecast
10.4.5 Russia CAR-T Cell Immunotherapy Market Forecast
10.5 Middle East & Africa CAR-T Cell Immunotherapy Forecast by Region (2023-2028)
10.5.1 Egypt CAR-T Cell Immunotherapy Market Forecast
10.5.2 South Africa CAR-T Cell Immunotherapy Market Forecast
10.5.3 Israel CAR-T Cell Immunotherapy Market Forecast
10.5.4 Turkey CAR-T Cell Immunotherapy Market Forecast
10.5.5 GCC Countries CAR-T Cell Immunotherapy Market Forecast
10.6 Global CAR-T Cell Immunotherapy Forecast by Type (2023-2028)
10.7 Global CAR-T Cell Immunotherapy Forecast by Application (2023-2028)
11 Key Players Analysis
11.1 Novartis AG
11.1.1 Novartis AG Company Information
11.1.2 Novartis AG CAR-T Cell Immunotherapy Product Offered
11.1.3 Novartis AG CAR-T Cell Immunotherapy Revenue, Gross Margin and Market Share (2020-2022)
11.1.4 Novartis AG Main Business Overview
11.1.5 Novartis AG Latest Developments
11.2 Kite Pharma
11.2.1 Kite Pharma Company Information
11.2.2 Kite Pharma CAR-T Cell Immunotherapy Product Offered
11.2.3 Kite Pharma CAR-T Cell Immunotherapy Revenue, Gross Margin and Market Share (2020-2022)
11.2.4 Kite Pharma Main Business Overview
11.2.5 Kite Pharma Latest Developments
11.3 JW Therapeutics
11.3.1 JW Therapeutics Company Information
11.3.2 JW Therapeutics CAR-T Cell Immunotherapy Product Offered
11.3.3 JW Therapeutics CAR-T Cell Immunotherapy Revenue, Gross Margin and Market Share (2020-2022)
11.3.4 JW Therapeutics Main Business Overview
11.3.5 JW Therapeutics Latest Developments
11.4 Shanghai Fosun Pharmaceutical Group
11.4.1 Shanghai Fosun Pharmaceutical Group Company Information
11.4.2 Shanghai Fosun Pharmaceutical Group CAR-T Cell Immunotherapy Product Offered
11.4.3 Shanghai Fosun Pharmaceutical Group CAR-T Cell Immunotherapy Revenue, Gross Margin and Market Share (2020-2022)
11.4.4 Shanghai Fosun Pharmaceutical Group Main Business Overview
11.4.5 Shanghai Fosun Pharmaceutical Group Latest Developments
12 Research Findings and Conclusion
Table 1. CAR-T Cell Immunotherapy Market Size CAGR by Region (2017 VS 2022 VS 2028) & ($ Millions)
Table 2. Major Players of CD19
Table 3. Major Players of CD22
Table 4. Major Players of Other
Table 5. CAR-T Cell Immunotherapy Market Size CAGR by Type (2017 VS 2022 VS 2028) & ($ Millions)
Table 6. Global CAR-T Cell Immunotherapy Market Size by Type (2017-2022) & ($ Millions)
Table 7. Global CAR-T Cell Immunotherapy Market Size Market Share by Type (2017-2022)
Table 8. CAR-T Cell Immunotherapy Market Size CAGR by Application (2017 VS 2022 VS 2028) & ($ Millions)
Table 9. Global CAR-T Cell Immunotherapy Market Size by Application (2017-2022) & ($ Millions)
Table 10. Global CAR-T Cell Immunotherapy Market Size Market Share by Application (2017-2022)
Table 11. Global CAR-T Cell Immunotherapy Revenue by Players (2020-2022) & ($ Millions)
Table 12. Global CAR-T Cell Immunotherapy Revenue Market Share by Player (2020-2022)
Table 13. CAR-T Cell Immunotherapy Key Players Head office and Products Offered
Table 14. CAR-T Cell Immunotherapy Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
Table 15. New Products and Potential Entrants
Table 16. Mergers & Acquisitions, Expansion
Table 17. Global CAR-T Cell Immunotherapy Market Size by Regions 2017-2022 & ($ Millions)
Table 18. Global CAR-T Cell Immunotherapy Market Size Market Share by Regions (2017-2022)
Table 19. Americas CAR-T Cell Immunotherapy Market Size by Country (2017-2022) & ($ Millions)
Table 20. Americas CAR-T Cell Immunotherapy Market Size Market Share by Country (2017-2022)
Table 21. Americas CAR-T Cell Immunotherapy Market Size by Type (2017-2022) & ($ Millions)
Table 22. Americas CAR-T Cell Immunotherapy Market Size Market Share by Type (2017-2022)
Table 23. Americas CAR-T Cell Immunotherapy Market Size by Application (2017-2022) & ($ Millions)
Table 24. Americas CAR-T Cell Immunotherapy Market Size Market Share by Application (2017-2022)
Table 25. APAC CAR-T Cell Immunotherapy Market Size by Region (2017-2022) & ($ Millions)
Table 26. APAC CAR-T Cell Immunotherapy Market Size Market Share by Region (2017-2022)
Table 27. APAC CAR-T Cell Immunotherapy Market Size by Type (2017-2022) & ($ Millions)
Table 28. APAC CAR-T Cell Immunotherapy Market Size Market Share by Type (2017-2022)
Table 29. APAC CAR-T Cell Immunotherapy Market Size by Application (2017-2022) & ($ Millions)
Table 30. APAC CAR-T Cell Immunotherapy Market Size Market Share by Application (2017-2022)
Table 31. Europe CAR-T Cell Immunotherapy Market Size by Country (2017-2022) & ($ Millions)
Table 32. Europe CAR-T Cell Immunotherapy Market Size Market Share by Country (2017-2022)
Table 33. Europe CAR-T Cell Immunotherapy Market Size by Type (2017-2022) & ($ Millions)
Table 34. Europe CAR-T Cell Immunotherapy Market Size Market Share by Type (2017-2022)
Table 35. Europe CAR-T Cell Immunotherapy Market Size by Application (2017-2022) & ($ Millions)
Table 36. Europe CAR-T Cell Immunotherapy Market Size Market Share by Application (2017-2022)
Table 37. Middle East & Africa CAR-T Cell Immunotherapy Market Size by Region (2017-2022) & ($ Millions)
Table 38. Middle East & Africa CAR-T Cell Immunotherapy Market Size Market Share by Region (2017-2022)
Table 39. Middle East & Africa CAR-T Cell Immunotherapy Market Size by Type (2017-2022) & ($ Millions)
Table 40. Middle East & Africa CAR-T Cell Immunotherapy Market Size Market Share by Type (2017-2022)
Table 41. Middle East & Africa CAR-T Cell Immunotherapy Market Size by Application (2017-2022) & ($ Millions)
Table 42. Middle East & Africa CAR-T Cell Immunotherapy Market Size Market Share by Application (2017-2022)
Table 43. Key Market Drivers & Growth Opportunities of CAR-T Cell Immunotherapy
Table 44. Key Market Challenges & Risks of CAR-T Cell Immunotherapy
Table 45. Key Industry Trends of CAR-T Cell Immunotherapy
Table 46. Global CAR-T Cell Immunotherapy Market Size Forecast by Regions (2023-2028) & ($ Millions)
Table 47. Global CAR-T Cell Immunotherapy Market Size Market Share Forecast by Regions (2023-2028)
Table 48. Global CAR-T Cell Immunotherapy Market Size Forecast by Type (2023-2028) & ($ Millions)
Table 49. Global CAR-T Cell Immunotherapy Market Size Market Share Forecast by Type (2023-2028)
Table 50. Global CAR-T Cell Immunotherapy Market Size Forecast by Application (2023-2028) & ($ Millions)
Table 51. Global CAR-T Cell Immunotherapy Market Size Market Share Forecast by Application (2023-2028)
Table 52. Novartis AG Details, Company Type, CAR-T Cell Immunotherapy Area Served and Its Competitors
Table 53. Novartis AG CAR-T Cell Immunotherapy Product Offered
Table 54. Novartis AG CAR-T Cell Immunotherapy Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 55. Novartis AG Main Business
Table 56. Novartis AG Latest Developments
Table 57. Kite Pharma Details, Company Type, CAR-T Cell Immunotherapy Area Served and Its Competitors
Table 58. Kite Pharma CAR-T Cell Immunotherapy Product Offered
Table 59. Kite Pharma Main Business
Table 60. Kite Pharma CAR-T Cell Immunotherapy Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 61. Kite Pharma Latest Developments
Table 62. JW Therapeutics Details, Company Type, CAR-T Cell Immunotherapy Area Served and Its Competitors
Table 63. JW Therapeutics CAR-T Cell Immunotherapy Product Offered
Table 64. JW Therapeutics Main Business
Table 65. JW Therapeutics CAR-T Cell Immunotherapy Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 66. JW Therapeutics Latest Developments
Table 67. Shanghai Fosun Pharmaceutical Group Details, Company Type, CAR-T Cell Immunotherapy Area Served and Its Competitors
Table 68. Shanghai Fosun Pharmaceutical Group CAR-T Cell Immunotherapy Product Offered
Table 69. Shanghai Fosun Pharmaceutical Group Main Business
Table 70. Shanghai Fosun Pharmaceutical Group CAR-T Cell Immunotherapy Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 71. Shanghai Fosun Pharmaceutical Group Latest Developments
List of Figures
Figure 1. CAR-T Cell Immunotherapy Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global CAR-T Cell Immunotherapy Market Size Growth Rate 2017-2028 ($ Millions)
Figure 6. Global CAR-T Cell Immunotherapy Market Size Market Share by Type in 2021
Figure 7. CAR-T Cell Immunotherapy in Relapsed or Refractory Mantle Cell Lymphoma (MCL)
Figure 8. Global CAR-T Cell Immunotherapy Market: Relapsed or Refractory Mantle Cell Lymphoma (MCL) (2017-2022) & ($ Millions)
Figure 9. CAR-T Cell Immunotherapy in High Grade B Cell Lymphoma
Figure 10. Global CAR-T Cell Immunotherapy Market: High Grade B Cell Lymphoma (2017-2022) & ($ Millions)
Figure 11. CAR-T Cell Immunotherapy in DLBCL
Figure 12. Global CAR-T Cell Immunotherapy Market: DLBCL (2017-2022) & ($ Millions)
Figure 13. CAR-T Cell Immunotherapy in Other
Figure 14. Global CAR-T Cell Immunotherapy Market: Other (2017-2022) & ($ Millions)
Figure 15. Global CAR-T Cell Immunotherapy Market Size Market Share by Application in 2021
Figure 16. Global CAR-T Cell Immunotherapy Revenue Market Share by Player in 2021
Figure 17. Global CAR-T Cell Immunotherapy Market Size Market Share by Regions (2017-2022)
Figure 18. Americas CAR-T Cell Immunotherapy Market Size 2017-2022 ($ Millions)
Figure 19. APAC CAR-T Cell Immunotherapy Market Size 2017-2022 ($ Millions)
Figure 20. Europe CAR-T Cell Immunotherapy Market Size 2017-2022 ($ Millions)
Figure 21. Middle East & Africa CAR-T Cell Immunotherapy Market Size 2017-2022 ($ Millions)
Figure 22. Americas CAR-T Cell Immunotherapy Value Market Share by Country in 2021
Figure 23. Americas CAR-T Cell Immunotherapy Consumption Market Share by Type in 2021
Figure 24. Americas CAR-T Cell Immunotherapy Market Size Market Share by Application in 2021
Figure 25. United States CAR-T Cell Immunotherapy Market Size Growth 2017-2022 ($ Millions)
Figure 26. Canada CAR-T Cell Immunotherapy Market Size Growth 2017-2022 ($ Millions)
Figure 27. Mexico CAR-T Cell Immunotherapy Market Size Growth 2017-2022 ($ Millions)
Figure 28. Brazil CAR-T Cell Immunotherapy Market Size Growth 2017-2022 ($ Millions)
Figure 29. APAC CAR-T Cell Immunotherapy Market Size Market Share by Region in 2021
Figure 30. APAC CAR-T Cell Immunotherapy Market Size Market Share by Application in 2021
Figure 31. China CAR-T Cell Immunotherapy Market Size Growth 2017-2022 ($ Millions)
Figure 32. Japan CAR-T Cell Immunotherapy Market Size Growth 2017-2022 ($ Millions)
Figure 33. Korea CAR-T Cell Immunotherapy Market Size Growth 2017-2022 ($ Millions)
Figure 34. Southeast Asia CAR-T Cell Immunotherapy Market Size Growth 2017-2022 ($ Millions)
Figure 35. India CAR-T Cell Immunotherapy Market Size Growth 2017-2022 ($ Millions)
Figure 36. Australia CAR-T Cell Immunotherapy Market Size Growth 2017-2022 ($ Millions)
Figure 37. Europe CAR-T Cell Immunotherapy Market Size Market Share by Country in 2021
Figure 38. Europe CAR-T Cell Immunotherapy Market Size Market Share by Type in 2021
Figure 39. Europe CAR-T Cell Immunotherapy Market Size Market Share by Application in 2021
Figure 40. Germany CAR-T Cell Immunotherapy Market Size Growth 2017-2022 ($ Millions)
Figure 41. France CAR-T Cell Immunotherapy Market Size Growth 2017-2022 ($ Millions)
Figure 42. UK CAR-T Cell Immunotherapy Market Size Growth 2017-2022 ($ Millions)
Figure 43. Italy CAR-T Cell Immunotherapy Market Size Growth 2017-2022 ($ Millions)
Figure 44. Russia CAR-T Cell Immunotherapy Market Size Growth 2017-2022 ($ Millions)
Figure 45. Middle East & Africa CAR-T Cell Immunotherapy Market Size Market Share by Region in 2021
Figure 46. Middle East & Africa CAR-T Cell Immunotherapy Market Size Market Share by Type in 2021
Figure 47. Middle East & Africa CAR-T Cell Immunotherapy Market Size Market Share by Application in 2021
Figure 48. Egypt CAR-T Cell Immunotherapy Market Size Growth 2017-2022 ($ Millions)
Figure 49. South Africa CAR-T Cell Immunotherapy Market Size Growth 2017-2022 ($ Millions)
Figure 50. Israel CAR-T Cell Immunotherapy Market Size Growth 2017-2022 ($ Millions)
Figure 51. Turkey CAR-T Cell Immunotherapy Market Size Growth 2017-2022 ($ Millions)
Figure 52. GCC Country CAR-T Cell Immunotherapy Market Size Growth 2017-2022 ($ Millions)
Figure 53. Americas CAR-T Cell Immunotherapy Market Size 2023-2028 ($ Millions)
Figure 54. APAC CAR-T Cell Immunotherapy Market Size 2023-2028 ($ Millions)
Figure 55. Europe CAR-T Cell Immunotherapy Market Size 2023-2028 ($ Millions)
Figure 56. Middle East & Africa CAR-T Cell Immunotherapy Market Size 2023-2028 ($ Millions)
Figure 57. United States CAR-T Cell Immunotherapy Market Size 2023-2028 ($ Millions)
Figure 58. Canada CAR-T Cell Immunotherapy Market Size 2023-2028 ($ Millions)
Figure 59. Mexico CAR-T Cell Immunotherapy Market Size 2023-2028 ($ Millions)
Figure 60. Brazil CAR-T Cell Immunotherapy Market Size 2023-2028 ($ Millions)
Figure 61. China CAR-T Cell Immunotherapy Market Size 2023-2028 ($ Millions)
Figure 62. Japan CAR-T Cell Immunotherapy Market Size 2023-2028 ($ Millions)
Figure 63. Korea CAR-T Cell Immunotherapy Market Size 2023-2028 ($ Millions)
Figure 64. Southeast Asia CAR-T Cell Immunotherapy Market Size 2023-2028 ($ Millions)
Figure 65. India CAR-T Cell Immunotherapy Market Size 2023-2028 ($ Millions)
Figure 66. Australia CAR-T Cell Immunotherapy Market Size 2023-2028 ($ Millions)
Figure 67. Germany CAR-T Cell Immunotherapy Market Size 2023-2028 ($ Millions)
Figure 68. France CAR-T Cell Immunotherapy Market Size 2023-2028 ($ Millions)
Figure 69. UK CAR-T Cell Immunotherapy Market Size 2023-2028 ($ Millions)
Figure 70. Italy CAR-T Cell Immunotherapy Market Size 2023-2028 ($ Millions)
Figure 71. Russia CAR-T Cell Immunotherapy Market Size 2023-2028 ($ Millions)
Figure 72. Spain CAR-T Cell Immunotherapy Market Size 2023-2028 ($ Millions)
Figure 73. Egypt CAR-T Cell Immunotherapy Market Size 2023-2028 ($ Millions)
Figure 74. South Africa CAR-T Cell Immunotherapy Market Size 2023-2028 ($ Millions)
Figure 75. Israel CAR-T Cell Immunotherapy Market Size 2023-2028 ($ Millions)
Figure 76. Turkey CAR-T Cell Immunotherapy Market Size 2023-2028 ($ Millions)
Figure 77. GCC Countries CAR-T Cell Immunotherapy Market Size 2023-2028 ($ Millions)
Similar Reports
This report provides an overview of the French molecular diagnostic testing market, including test volume, and sales forecasts by Application, 2019-2023, and supplier shares by test.
Table of Contents
Business Environment
Market Structure
Market Size, Growth, and Major Suppliers' Market Shares
This report provides an overview of the German molecular diagnostic testing market, including test volume, and sales forecasts by application, and supplier shares by test.
Table of Contents
Business Environment
Market Structure
Market Size, Growth, and Major Suppliers' Market Shares
&nb...
- Publish Date: April 1, 2019
- $450
This report provides an overview of the Italian molecular diagnostic testing market, including test volume, and sales forecasts by application, and supplier shares by test.
Table of Contents
Business Environment
Market Structure
Market Size, Growth, and Major Suppliers' Market Shares
&nb...
- Publish Date: April 1, 2019
- $450
